The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pharmacological Characterization of Olodaterol, a Novel Inhaled β2-Adrenoceptor Agonist Exerting a 24-Hour-Long Duration of Action in Preclinical Models
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Research works printed but not linked: 26
- Barnes, 2004, The role of anticholinergics in chronic obstructive pulmonary disease, Am J Med, 117, 24S
- Bender, 2002, Overcoming barriers to nonadherence in asthma treatment, J Allergy Clin Immunol, 109, S554, 10.1067/mai.2002.124570 · DOI · Paper page
- Braman, 2006, The global burden of asthma, Chest, 130, 4S, 10.1378/chest.130.1_suppl.4S · DOI · Paper page
- Casarosa, 2009, Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs, J Pharmacol Exp Ther, 330, 660, 10.1124/jpet.109.152470 · DOI
- Casarosa, 2005, CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor, J Biol Chem, 280, 3275, 10.1074/jbc.M407536200 · doi:10.1074/jbc.m407536200
- Cazzola, 2008, Novel long-acting bronchodilators for COPD and asthma, Br J Pharmacol, 155, 291, 10.1038/bjp.2008.284 · DOI
- Dalby, 2004, A review of the development of Respimat Soft Mist Inhaler, Int J Pharm, 283, 1, 10.1016/j.ijpharm.2004.06.018 · doi:10.1016/j.ijpharm.2004.06.018
- Gold, 2009, The 2007 GOLD Guidelines: a comprehensive care framework, Respir Care, 54, 1040
- Greaves, 1998, Patterns of drug-induced cardiovascular pathology in the beagle dog: relevance for humans, Exp Toxicol Pathol, 50, 283, 10.1016/S0940-2993(98)80008-0 · DOI
- Greaves, 2000, Patterns of cardiovascular pathology induced by diverse cardioactive drugs, Toxicol Lett, 112–113, 547, 10.1016/S0378-4274(99)00222-2 · DOI
- Guerra, 2009, Asthma and chronic obstructive pulmonary disease, Curr Opin Allergy Clin Immunol, 9, 409, 10.1097/ACI.0b013e3283300baf · DOI
- Jenkins, 2009, Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study, Respir Res, 10, 59, 10.1186/1465-9921-10-59 · DOI · Paper page
- Kenakin, 2004, Principles: receptor theory in pharmacology, Trends Pharmacol Sci, 25, 186, 10.1016/j.tips.2004.02.012 · DOI · Paper page
- Larj, 2002, Effects of β2-agonists on airway tone and bronchial responsiveness, J Allergy Clin Immunol, 110, S304, 10.1067/mai.2002.130045 · DOI
- Lipworth, 1997, Evaluation of partial β-adrenoceptor agonist activity, Br J Clin Pharmacol, 43, 9
- Mak, 1994, High affinity [3H]formoterol binding sites in lung: characterization and autoradiographic mapping, Eur J Pharmacol, 269, 35, 10.1016/0922-4106(94)90023-X · doi:10.1016/0922-4106(94)90023-x
- Meng, 1999, Compliance with U.S. asthma management guidelines and specialty care: a regional variation or national concern?, J Eval Clin Pract, 5, 213, 10.1046/j.1365-2753.1999.00177.x · DOI
- Naline, 1994, Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus, Eur Respir J, 7, 914, 10.1183/09031936.94.07050914 · doi:10.1183/09031936.94.07050914
- Naline, 2007, Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi, Eur Respir J, 29, 575, 10.1183/09031936.00032806 · doi:10.1183/09031936.00032806
- O'Byrne, 2009, Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma, J Allergy Clin Immunol, 124, 1217, 10.1016/j.jaci.2009.08.047 · DOI
- Pauwels, 2004, Burden and clinical features of chronic obstructive pulmonary disease (COPD), Lancet, 364, 613, 10.1016/S0140-6736(04)16855-4 · DOI · Paper page
- Sovani, 2004, A benefit-risk assessment of inhaled long-acting β2-agonists in the management of obstructive pulmonary disease, Drug Saf, 27, 689, 10.2165/00002018-200427100-00001 · doi:10.2165/00002018-200427100-00001
- Tamura, 2007, Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch, Respir Med, 101, 1895, 10.1016/j.rmed.2007.05.001 · doi:10.1016/j.rmed.2007.05.001
- Tashkin, 2008, A 4-year trial of tiotropium in chronic obstructive pulmonary disease 7, N Engl J Med, 359, 1543, 10.1056/NEJMoa0805800 · DOI · Paper page
- Van Noord, 2009, Four weeks once daily treatment with BI 1744 CL, a novel long-acting β2-agonist, is effective in COPD patients, Am J Respir Crit Care Med, 179, A6183
- Walland, 1997, Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs, Eur J Pharmacol, 330, 213, 10.1016/S0014-2999(97)01011-X · doi:10.1016/s0014-2999(97)01011-x
Cited by
Pharmacology and Therapeutics of Bronchodilators
Cazzola, M., Page, C. P., Calzetta, L., & Matera, M. G. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004580 · Cited by 467
β 2 -Agonist Therapy in Lung Disease
Cazzola, M., Page, C. P., Rogliani, P., & Matera, M. G. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1739pp · Cited by 262
Use of precision cut lung slices as a translational model for the study of lung biology
Liu, G., Betts, C., Cunoosamy, D. M., Åberg, P. M., Hornberg, J. J., Sivars, K. B., & Cohen, T. S. (2019) · Respiratory Research · doi:10.1186/s12931-019-1131-x · Cited by 206
Roth, B. L., & Kroeze, W. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.654764 · Cited by 88
Metadata
- Authors
- Bouyssou, T., Casarosa, P., Naline, E., Pestel, S., Konetzki, I., Devillier, P., & Schnapp, A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 334
- Issue
- 1
- Pages
- 53-62
- ISSN
- 0022-3565
- Cited by
- 95
- References
- 2
- Language
- en
- Update notices
- erratum (2013-07-01)
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological Characterization of Olodaterol, a Novel Inhaled β2-Adrenoceptor Agonist Exerting a 24-Hour-Long Duration of Action in Preclinical Models. https://app.cochat.ai/papers/10.1124/jpet.110.167007
- The paper
- Bouyssou, T., Casarosa, P., Naline, E., Pestel, S., Konetzki, I., Devillier, P., & Schnapp, A. (2010). Pharmacological Characterization of Olodaterol, a Novel Inhaled β2-Adrenoceptor Agonist Exerting a 24-Hour-Long Duration of Action in Preclinical Models. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.110.167007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.